More than 700 cough syrup manufacturers were subjected to aggravated audit and accrued marketplace surveillance sampling of syrup formulations was done by cardinal and authorities drugs regulators successful the aftermath of children deaths allegedly owed to depletion of contaminated cough syrups, Rajya Sabha was informed connected Tuesday (December 2, 2025).
Upon receipt of reports of a clump of kid deaths from Chhindwara, Madhya Pradesh, a cardinal squad of experts visited Chhindwara and Nagpur and undertook a elaborate probe of the reported cases and deaths successful coordination with the Madhya Pradesh authorities authorities, Minister of State for Health Anupriya Patel said successful a written reply.
The squad comprised an epidemiologist, a microbiologist, an entomologist, and cause inspectors from the National Centre for Disease Control (NCDC), National Institute of Virology (NIV), and Central Drugs Standard Control Organisation (CDSCO).
A full of 19 cause samples, reportedly consumed by the affected children, were collected from the treating backstage practitioners and adjacent retail stores for testing, Ms. Patel said.
"Chemical investigation of these 19 samples indicated that 15 samples were of modular quality, portion 4 samples were declared not of modular prime (NSQ)," she stated.
Diethylene Glycol (DEG) successful Coldrif syrup
"As per the trial report, the contented of Diethylene Glycol (DEG) successful Syrup Coldrif manufactured by Sresan Pharmaceutical located successful Kancheepuram, Tamil Nadu and consumed by the deceased children was recovered to beryllium 46.28% w/v," Ms. Patel said successful her reply.
The premises of M/s Sresan Pharmaceuticals was inspected. Several captious and large bully manufacturing practices violations including unhygienic retention conditions were observed, the substance regarding the transgression enactment against the shaper was taken up by CDSCO with the Tamil Nadu government, she said.
Further, pursuing the incident, Madhya Pradesh, Tamil Nadu, Odisha and Puducherry, wherever the impugned cough syrup batches were supplied, ordered contiguous prohibition and recall, Ms. Patel informed.
Criminal lawsuit has been registered successful the substance by Madhya Pradesh and strict enactment has been taken including the apprehension of persons involved.
An advisory has been issued connected October 3 to wellness departments and healthcare facilities of each states and Union territories to guarantee rational usage of paediatric cough syrups, Ms. Patel said.
Further, the Drugs Controller (India) directed each states and Union territories cause controllers connected October 7 to guarantee strict compliance with investigating requirements nether the Drugs Rules, 1945, and connected October 21 instructed them to support heightened vigilance against spurious and substandard drugs and instrumentality punctual enactment nether the Drugs and Cosmetics Act, 1940.
"More than 700 cough syrup manufacturers person been subjected to aggravated audit successful coordination with authorities authorities and accrued marketplace surveillance sampling of syrup formulations by cardinal and authorities drugs regulators has besides been done," Ms. Patel stated.
In summation to the existing requirements of investigating the earthy materials, the Indian Pharmacopoeia Commission, Ghaziabad has issued an amendment to Indian Pharmacopoeia (IP) 2022, to besides mandate the investigating for DEG and Ethylene Glycol (EG) successful oral liquids astatine finished merchandise signifier earlier marketplace release, she said.

5 months ago
1




